Pharmaceutical Nanotechnology

Nanotechnology is manipulation of matter on an atomic, molecular and supra molecular scale. Nanotechnology advances the utilization of materials and devices with extremely small dimensions. Nanotechnology is designed to provide a new and improved approach to cancer diagnosis and treatment. Nano scale devices can interact with large biological molecules on the both surface and inside cells involved in cancer.   

• Nanobiotechnology
• Nanomedicine
• Nanomaterials for Drug Delivery
• Personalized Nanomedicine
• Nano Drug Delivery and Nanotoxicity

Pharmaceutics Conferences  inviting workshop proposals which covers Engineering of Pharmaceutical Nano systems, Chartecterisation of pharmaceutical Nano tools, Applications of Pharmaceutical Nano tools, Challenges to Pharmaceutical Nanotechnology.

Clinical Pharmacy Conferences  welcoming short course proposals on Future Prospects of Pharmaceutical Nanotechnology.

Market Statistics:

The Nanotechnology in Drug Delivery market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. The Global Nanotechnology in Drug Delivery Market is expected to grow at a CAGR of 19.9% from 2021-2027 to reach USD 182.3 billion by 2027. Since 1995, nearly 50 nano pharmaceuticals have received FDA approval and are currently available for clinical use. In oncology, over 20% of the therapeutic nanoparticles already in clinics or under clinical evaluation have been created. Most FDA-approved therapeutic nanoparticles are currently being designed for the re-formulation of combinations of chemotherapeutic drugs with polymeric nanoparticles.